Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0759
D

Failure to Prime Insulin Pens Results in Medication Error Rate Above 5%

Parma, Ohio Survey Completed on 11-25-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to maintain a medication error rate below 5%, as required, with a calculated error rate of 6.45% based on 31 observed medication administrations and two identified errors. Both errors involved the administration of insulin using pen injectors for two residents with diabetes and chronic kidney disease. In both cases, the LPNs administering the insulin did not prime the insulin pens prior to dialing the prescribed dose and administering the medication, contrary to manufacturer instructions and facility policy. The LPNs confirmed during interviews that they did not prime the pens, with one stating she only primes if air bubbles are visible and the other stating she did not believe priming was necessary. The residents involved were cognitively intact and had care plans and physician orders specifying insulin administration for diabetes management. The facility's policy and the insulin pen manufacturer’s instructions both require priming the pen after attaching a new needle and before setting the prescribed dose. The DON confirmed that the correct procedure was not followed in these instances. The deficiency was identified during a complaint investigation and was substantiated by direct observation, record review, and staff interviews.

An unhandled error has occurred. Reload 🗙